缩窄性心包炎心包切除同期三尖瓣手术的结局
该队列研究纳入2000至2016年Mayo Clinic因缩窄性心包炎行心包切除且伴轻度及以上三尖瓣反流的310例患者,比较同期三尖瓣手术(n=68)与未手术(n=242)的结局。同期三尖瓣手术未增加手术死亡率,并可能降低长期死亡率、残余三尖瓣反流和右心室扩大风险。
要点
- 同期三尖瓣手术未增加手术死亡率(9% vs 6%,P=.422)。
- 三尖瓣手术与随访时较轻三尖瓣反流相关(OR 0.093)。
- 残余严重右心室功能障碍增加死亡风险(HR 4.87)。
核心结论
- 缩窄性心包炎心包切除同期三尖瓣手术不增加手术死亡率。
- 三尖瓣手术可能对长期死亡率、残余三尖瓣反流和右心室扩大有保护作用。
研究设计与样本
- 回顾性队列研究,纳入2000至2016年Mayo Clinic Rochester因缩窄性心包炎行心包切除且伴轻度及以上三尖瓣反流的310例患者。
- 按治疗分为三尖瓣手术组(n=68)和未手术组(n=242)。
- 采用生存分析、比例优势模型和界标分析评估治疗效果。
主要发现
- 三尖瓣反流程度:轻度203例(65%),中度69例(22%),重度38例(12%)。
- 三尖瓣手术方式:修复54例(17%),置换14例(5%)。
- 机械循环支持使用率手术组更高(15% vs 5%;P=.009)。
- 卒中率(3% vs 2%;P=.210)和死亡率(9% vs 6%;P=.422)两组相似。
- 三尖瓣手术与长期死亡率降低相关(HR 0.68;95%CI 0.38-1.21;P=.192)。
临床怎么用
- 缩窄性心包炎伴轻度及以上三尖瓣反流患者行心包切除时,可考虑同期三尖瓣手术而不必担心手术死亡率增加。
- 同期三尖瓣手术可能减少远期残余三尖瓣反流和右心室扩大,并可能改善长期生存。
- 术后应关注残余右心室功能,严重右心室功能障碍与死亡风险增加相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study sought to determine the outcome effect of concomitant tricuspid valve operation for regurgitation during pericardiectomy for constrictive pericarditis. METHODS: This cohort study included 310 patients with mild or greater tricuspid valve regurgitation who underwent pericardiectomy for constrictive pericarditis from 2000 to 2016 at the Mayo Clinic in Rochester, Minnesota. Patients were divided into 2 treatment groups: tricuspid valve operation (n = 68) and no tricuspid operation (n = 242). Survival analysis, proportional odds models, and landmark analysis were carried out to estimate the treatment effects of tricuspid valve operation. RESULTS: Tricuspid valve regurgitation was graded mild in 203 (65%) patients, moderate in 69 (22%), and severe in 38 (12%). Tricuspid valve operation included repair in 54 patients (17%) and replacement in 14 (5%). Mechanical circulatory support was used more commonly in the intervention group (15% vs 5%; P = .009), but rates of stroke (3% vs 2%; P = .210) and mortality (9% vs 6%; P = .422) were similar. Tricuspid valve intervention resulted in a reduced risk of long-term mortality (hazard ratio, 0.68; 95% confidence interval [CI], 0.38 to 1.21; P = .192), less than moderate tricuspid valve regurgitation at follow-up (odds ratio vs moderate or severe, 0.093; 95% CI, 0.04 to 0.19), and less than moderate right ventricular enlargement at follow-up (odds ratio vs moderate or severe, 0.67; 95% CI, 0.35 to 1.24). Remnant severe right ventricular dysfunction resulted in increased risk of mortality (hazard ratio vs none or trivial, 4.87; 95% CI, 1.10 to 21.65; P = .037). CONCLUSIONS: Concomitant tricuspid valve operation for regurgitation can be performed without increased operative mortality during pericardiectomy for constrictive pericarditis. Operation appears protective against long-term mortality, residual tricuspid regurgitation, and right ventricular enlargement.
引用
- Calderon-Rojas RD, Greason KL, King KS, et al. Outcomes of Tricuspid Valve Operation at the Time of Pericardiectomy for Constrictive Pericarditis. Ann Thorac Surg. 2020. PMID: 32896543. doi:10.1016/j.athoracsur.2020.06.106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。